Home/Pipeline/Glaucoma Diagnostics

Glaucoma Diagnostics

Glaucoma

Development/AccreditationActive

Key Facts

Indication

Glaucoma

Phase

Development/Accreditation

Status

Active

Company

Avellino Laboratories

About Avellino Laboratories

Avellino Laboratories is a private, precision health company founded in 2007 and headquartered in Menlo Park, California. It operates at the intersection of genomics, diagnostics, and AI/ML, with a pipeline targeting genetic diagnostics for glaucoma, macular degeneration, oncology, and pathogenomics. The company appears to be in a commercial stage for its diagnostic services (e.g., COVID & RSV testing) while developing its therapeutic pipeline, positioning it as a data-driven player in the growing field of predictive and personalized medicine.

View full company profile

Therapeutic Areas

Ophthalmology Oncology Infectious Disease

Other Glaucoma Drugs

Drug	Company	Phase	Status
PREZIA Glaucoma Implant	PolyActiva	Preclinical	Active
MIGS Device System	Micropoint Biotechnologies	Commercial	Market approved in China
INM-088	InMed Pharmaceuticals	Preclinical	Active
OT-401	Ocumension Therapeutics	Phase 2	Active
ANX007	Annexon Biosciences	Phase 2	Active
PER-001	Perfuse Therapeutics	Phase 2	Active
hOTX2	BrainEver	Discovery	Active
Glaucoma Treatment	BVI Medical	Commercial	Active
MediPrint Lens (Glaucoma)	MediPrint Ophthalmics	Phase 2b	Active
Glaucoma Program	Broadwing Bio	Pre-clinical	Active
MSC Exosomal Eye Serum	Vitti Labs	Pre-clinical	Active
BTQ1902	Betaliq	Phase 2	Active